From Tregs to tissue remodelling: FOXP3 and IL-35 in the inflammatory landscape of nasal polyps. [PDF]
Gokulakannan G +6 more
europepmc +1 more source
Histopathological differences between antrochoanal polyps and chronic rhinosinusitis with nasal polyps in pediatric patients. [PDF]
Han Y, Liu Y, Yu B, Lin X, Bi J, Fu Y.
europepmc +1 more source
Factors Associated With Dupilumab Efficacy in Patients With Chronic Rhinosinusitis With Nasal Polyps. [PDF]
Takaishi S, Otori N.
europepmc +1 more source
Heterogeneity and clinical relevance of group 2 innate lymphoid cells subsets in nasal polyps. [PDF]
Kidoguchi M +22 more
europepmc +1 more source
Association between 8-OHdG Levels and Eosinophil Counts in Chronic Rhinosinusitis with Nasal Polyps. [PDF]
Vieira TS +9 more
europepmc +1 more source
Tissue eosinophilia suggests dupilumab treatment response in chronic rhinosinusitis with nasal polyps (CRSwNP). [PDF]
Huber P +6 more
europepmc +1 more source
Depemokimab: A twice yearly anti-IL 5 biologic for chronic rhinosinusitis with nasal polyps (CRSwNP) - A narrative review. [PDF]
Park MJ, Han JK, Lam KK.
europepmc +1 more source
Ultrastructural Mucosal Response to Dupilumab in Chronic Rhinosinusitis With Nasal Polyps: A Pilot Study. [PDF]
Giombi F +12 more
europepmc +1 more source
The exploration of immunological landscape and drug targets in chronic rhinosinusitis with nasal polyps. [PDF]
Zhang R, Fu P, Tian H.
europepmc +1 more source

